We are live on ! Find out more
P8IP

Pier 88 Investment Partners Portfolio holdings

AUM $421M
1-Year Est. Return 14.71%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+14.71%
3 Year Est. Return
+36.1%
5 Year Est. Return
+43.13%
10 Year Est. Return
–
AUM
$446M
AUM Growth
+$39M
Cap. Flow
-$228M
Cap. Flow %
-51.05%
Top 10 Hldgs %
46.7%
Holding
104
New
5
Increased
55
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.6M
2
COHR icon
Coherent
COHR
+$2.43M
3
FOUR icon
Shift4
FOUR
+$1.87M
4
CRWD icon
CrowdStrike
CRWD
+$1.41M
5
WIX icon
WIX.com
WIX
+$1.29M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.04M
2
KBR icon
KBR
KBR
+$1.65M
3
TW icon
Tradeweb Markets
TW
+$1.63M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$1.57M
5
KKR icon
KKR & Co
KKR
+$1.47M

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Healthcare 3.25%
3 Consumer Discretionary 2.56%
4 Industrials 2.49%
5 Consumer Staples 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MEDP icon
51
Medpace
MEDP
$16.8B
$754K 0.17%
1,830
+720
+65% +$285K
PETQ
52
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$719K 0.16%
+32,600
New +$626K
RCKT icon
53
Rocket Pharmaceuticals
RCKT
$397M
$665K 0.15%
30,900
+12,900
+72% +$296K
KRYS icon
54
Krystal Biotech
KRYS
$9.81B
$617K 0.14%
3,360
+2,190
+187% +$368K
TW icon
55
Tradeweb Markets
TW
$21.9B
$616K 0.14%
5,815
-15,385
-73% -$1.63M
SLAB icon
56
Silicon Laboratories
SLAB
$7.2B
$533K 0.12%
4,822
+1,410
+41% +$174K
RCM
57
DELISTED
R1 RCM Inc. Common Stock
RCM
$494K 0.11%
39,360
-7,120
-15% -$88.6K
NBIX icon
58
Neurocrine Biosciences
NBIX
$16.8B
$489K 0.11%
3,550
+2,100
+145% +$288K
ABCL icon
59
AbCellera Biologics
ABCL
$2.85B
$478K 0.11%
161,620
+126,640
+362% +$479K
IOVA icon
60
Iovance Biotherapeutics
IOVA
$2.9B
$470K 0.11%
58,580
+35,680
+156% +$382K
ABSI icon
61
Absci
ABSI
$1.53B
$457K 0.1%
148,220
+104,650
+240% +$485K
KKR icon
62
KKR & Co
KKR
$93.2B
$442K 0.1%
4,200
-14,400
-77% -$1.47M
HELE icon
63
Helen of Troy
HELE
$680M
$412K 0.09%
4,445
+2,130
+92% +$216K
ATI icon
64
ATI
ATI
$31.1B
$410K 0.09%
7,400
+4,900
+196% +$275K
KEYS icon
65
Keysight
KEYS
$57.3B
$399K 0.09%
2,915
+1,900
+187% +$278K
NVDA icon
66
NVIDIA
NVDA
$5.27T
$395K 0.09%
3,200
-20,200
-86% -$2.04M
PYXS icon
67
Pyxis Oncology
PYXS
$243M
$376K 0.08%
113,700
+62,340
+121% +$262K
DTE icon
68
DTE Energy
DTE
$28.5B
$321K 0.07%
2,894
– –
TXG icon
69
10x Genomics
TXG
$7.63B
$253K 0.06%
13,000
+5,900
+83% +$154K
D icon
70
Dominion Energy
D
$59.1B
$211K 0.05%
4,315
– –
RXRX icon
71
Recursion Pharmaceuticals
RXRX
$1.76B
$185K 0.04%
+24,700
New +$215K
RVLV icon
72
Revolve Group
RVLV
$1.73B
$182K 0.04%
+11,470
New +$220K
EQX icon
73
Equinox Gold
EQX
$13.5B
$104K 0.02%
19,900
– –
FIVE icon
74
Five Below
FIVE
$13B
$65.4K 0.01%
600
– –
ADPT icon
75
Adaptive Biotechnologies
ADPT
$4.05B
– –
-26,415
Closed -$84.8K
1 2
3
4

Similar funds

BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
CWAF
Core Wealth Advisors (Florida) Lakeland, Florida $419M AUM 16.86% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return

Pier 88 Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Pier 88 Investment Partners held 104 positions worth $446M, up 9.6% from $407M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pier 88 Investment Partners withdrew a net $228M in Q2 2024, closing 8 positions and reducing 8 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $1.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Pier 88 Investment Partners opened a new position in Alphabet (Google) Class A worth $2.81M.

  • Pier 88 Investment Partners's largest Q2 2024 buy was Alphabet (Google) Class A: 15,400 shares worth $2.81M.
  • Pier 88 Investment Partners added most to Shift4 in Q2 2024, an estimated $1.87M increase.
  • Pier 88 Investment Partners's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.04M.
  • Pier 88 Investment Partners fully exited iShares Russell 2000 Growth ETF in Q2 2024, selling an estimated $1.57M.
  • Pier 88 Investment Partners's ten largest holdings make up 47% of its $446M portfolio in Q2 2024.
  • Pier 88 Investment Partners opened 5 new positions and closed 8 in Q2 2024.
  • Pier 88 Investment Partners's portfolio value rose 9.6% quarter-over-quarter to $446M.

Based on Pier 88 Investment Partners's 13F filing for Q2 2024, filed 6 Aug 2024.